AngioSlide

AngioSlide is a medical device company based in Israel that develops and markets the PROTEUS system, an FDA cleared embolic capture angioplasty device used to treat peripheral artery disease. The private firm generates revenue through commercial sales of its proprietary technology to hospitals and physicians performing complex lower limb vascular interventions. This unique system combines traditional balloon angioplasty with suction capabilities to capture and safely remove dislodged embolic particles from the bloodstream during surgical procedures. Operating with fewer than 25 employees and generating under five million dollars in annual revenue, the company has raised nearly 25 million dollars in total venture capital funding across three investment rounds. Founded in 2005 by Eran Hirszowicz, Amos Nahir, and Asher Holzer, the organization is backed by a syndicate of institutional investors including TriVentures, Viola Partners, Agate Medical Investments, and XT Investments.